PHARMACOKINETIC COMPARISON OF AMLODIPINE/LOSARTAN/ROSUVASTATIN FIXED-DOSE COMBINATION AND AMLODIPINE/LOSARTANFIXED-DOSE COMBINATION WITH ROUSUVASTATIN TABLET.

被引：0
|
作者：
Ban, M. [1 ]
Lee, S. [1 ]
Ryou, J. -H. [1 ]
Kim, E. [1 ]
Son, H. [2 ]
Jung, J. [2 ]
Yu, K. -S. [1 ]
Chung, J. -Y. [3 ,4 ]
机构：
[1] Seoul Natl Univ, Dept Clin Pharmacol & Therapeut, Coll Med & Hosp, Seoul, South Korea
[2] Hanmi Pharmaceut Co Ltd, Seoul, South Korea
[3] Seoul Natl Univ, Dept Clin Pharmacol & Therapeut, Coll Med, Seongnam, South Korea
[4] Bundang Hosp, Seongnam, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-037
引用
收藏
页码：S24 / S25
页数：2
相关论文
共 50 条
  • [31] Pharmacokinetic comparison of amlodipine adipate/valsartan and amlodipine besylate/valsartan as fixed-dose combinations in healthy volunteers
    Nam, Ju-Hyun
    Oh, Minkyung
    Kim, Hyun Ji
    Han, Sung Kyun
    Kim, Eun Ji
    Song, Geun Seog
    Kim, Eun-Young
    Shin, Jae-Gook
    Ghim, Jong-Lyul
    Kim, Ho-Sook
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (01) : 66 - 74
  • [32] Investigation of a potential pharmacokinetic interaction between perindopril arginine and amlodipine when administered as a single perindopril/amlodipine fixed-dose combination tablet in healthy Chinese male volunteers
    Zheng, Xin
    Liu, Tao
    Chen, Xia
    Chen, Xiaoyan
    Jiang, Ji
    Hu, Pei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (01) : 43 - 51
  • [33] Pharmacokinetic and Pharmacodynamic Profiles of a Fixed-Dose Combination of Olmesartan Medoxomil and Amlodipine in Healthy Chinese Males and Females
    Xia Chen
    Pei Hu
    Ji Jiang
    Tao Liu
    Wen Zhong
    Hongzhong Liu
    Qian Zhao
    Clinical Drug Investigation, 2012, 32 : 783 - 790
  • [34] Pharmacokinetic and Pharmacodynamic Profiles of a Fixed-Dose Combination of Olmesartan Medoxomil and Amlodipine in Healthy Chinese Males and Females
    Chen, Xia
    Hu, Pei
    Jiang, Ji
    Liu, Tao
    Zhong, Wen
    Liu, Hongzhong
    Zhao, Qian
    CLINICAL DRUG INVESTIGATION, 2012, 32 (12) : 783 - 790
  • [35] The relative bioavailability of 2 prototype fixed-dose combination formulations for amlodipine and rosuvastatin in healthy white and Chinese subjects
    Nwe, Htar H.
    Bullman, Jonathan N.
    Joshi, Shashidhar M.
    Stylianou, Annie
    Kapsi, Shiva G.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (02): : 131 - 140
  • [36] Clinical Impact of Patient Adherence to a Fixed-Dose Combination of Olmesartan, Amlodipine and Hydrochlorothiazide
    Bramlage, Peter
    Ketelhut, Reinhard
    Fronk, Eva-Maria
    Wolf, Wolf-Peter
    Smolnik, Ruediger
    Zemmrich, Claudia
    Schmieder, Roland E.
    CLINICAL DRUG INVESTIGATION, 2014, 34 (06) : 403 - 411
  • [37] A growing evidence base for the fixed-dose combination of bisoprolol and amlodipine to manage hypertension
    Hostalek-Gottwald, Ulrike
    Gaciong, Zbigniew
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (07) : 1047 - 1053
  • [38] Economic evaluation of olmesartan/amlodipine fixed-dose combination for hypertension treatment in China
    Ren, Maodong
    Xuan, Dennis
    Lu, Yongji
    Fu, YuYan
    Xuan, Jianwei
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (04) : 394 - 400
  • [39] A Fixed-Dose Combination of Bisoprolol and Amlodipine for Hypertension: A Potential Benefit to Selected Patients
    Cohen, Brian J.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (01): : 6 - 8
  • [40] Efficacy of Fixed-Dose Combination Therapy in the Treatment of Patients with HypertensionFocus on Amlodipine/Valsartan
    Pedro Marques da Silva
    Clinical Drug Investigation, 2010, 30 : 625 - 641
12345